Marshall Wace’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-131,070
| Closed | -$24.1M | – | 4116 |
|
|
2021
Q2 | $24.1M | Sell |
131,070
-225,196
| -63% | -$38.7M | 0.13% | 200 |
|
|
2021
Q1 | $54.5M | Buy |
356,266
+189,797
| +114% | +$29.4M | 0.29% | 71 |
|
|
2020
Q4 | $26M | Buy |
166,469
+117,008
| +237% | +$15M | 0.16% | 147 |
|
|
2020
Q3 | $5.66M | Sell |
49,461
-267,823
| -84% | -$28.9M | 0.04% | 477 |
|
|
2020
Q2 | $35.6M | Buy |
317,284
+207,469
| +189% | +$22M | 0.28% | 88 |
|
|
2020
Q1 | $9.86M | Buy |
109,815
+1,582
| +1% | +$155K | 0.1% | 215 |
|
|
2019
Q4 | $11.7M | Buy |
108,233
+18,250
| +20% | +$1.95M | 0.09% | 287 |
|
|
2019
Q3 | $8.81M | Sell |
89,983
-88,637
| -50% | -$9.99M | 0.07% | 327 |
|
|
2019
Q2 | $23.4M | Buy |
178,620
+117,490
| +192% | +$15.1M | 0.2% | 107 |
|
|
2019
Q1 | $8.26M | Buy |
61,130
+33,871
| +124% | +$4.21M | 0.08% | 313 |
|
|
2018
Q4 | $2.65M | Buy |
27,259
+21,068
| +340% | +$2.49M | 0.03% | 658 |
|
|
2018
Q3 | $861K | Sell |
6,191
-223,466
| -97% | -$28M | 0.01% | 839 |
|
|
2018
Q2 | $28.5M | Buy |
229,657
+216,380
| +1,630% | +$25.3M | 0.43% | 60 |
|
|
2018
Q1 | $1.48M | Buy |
+13,277
| New | +$1.59M | 0.06% | 229 |
|
|
2017
Q4 | – | Sell |
-2,973
| Closed | -$416K | – | 505 |
|
|
2017
Q3 | $416K | Sell |
2,973
-531
| -15% | -$72.1K | 0.02% | 291 |
|
|
2017
Q2 | $427K | Sell |
3,504
-15,632
| -82% | -$1.82M | 0.02% | 253 |
|
|
2017
Q1 | $2.31M | Sell |
19,136
-79,196
| -81% | -$10.2M | 0.11% | 127 |
|
|
2016
Q4 | $12M | Sell |
98,332
-329,362
| -77% | -$40.3M | 0.08% | 290 |
|
|
2016
Q3 | $52.4M | Buy |
427,694
+342,472
| +402% | +$44.1M | 0.37% | 65 |
|
|
2016
Q2 | $9.95M | Buy |
85,222
+72,741
| +583% | +$10.3M | 0.09% | 250 |
|
|
2016
Q1 | $1.74M | Sell |
12,481
-39,248
| -76% | -$5.76M | 0.02% | 590 |
|
|
2015
Q4 | $9.87M | Buy |
+51,729
| New | +$9.04M | 0.09% | 227 |
|
|
2015
Q3 | – | Sell |
-10,671
| Closed | -$1.93M | – | 1110 |
|
|
2015
Q2 | $1.93M | Sell |
10,671
-233,306
| -96% | -$40.3M | 0.03% | 483 |
|
|
2015
Q1 | $42.3M | Buy |
243,977
+82,215
| +51% | +$14.9M | 0.55% | 37 |
|
|
2014
Q4 | $29.9M | Sell |
161,762
-53,922
| -25% | -$9.99M | 0.4% | 64 |
|
|
2014
Q3 | $35.8M | Buy |
215,684
+162,413
| +305% | +$26.7M | 0.52% | 43 |
|
|
2014
Q2 | $8.32M | Sell |
53,271
-8,299
| -13% | -$1.31M | 0.12% | 194 |
|
|
2014
Q1 | $9.37M | Buy |
+61,570
| New | +$9.79M | 0.17% | 164 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM